Login / Signup

Reduced numbers of regulatory T cells in chronic heart failure seems not to be restored by cardiac resynchronization therapy.

Sílvia MartinsNatália AntónioTiago CarvalheiroPaula LaranjeiraRicardo RodriguesLino M GonçalvesCândida Teixeira TomazArtur Paiva
Published in: BMC cardiovascular disorders (2023)
Observational and prospective study with no trial registration.
Keyphrases
  • regulatory t cells
  • cardiac resynchronization therapy
  • left ventricular
  • heart failure
  • dendritic cells
  • phase iii
  • study protocol
  • phase ii
  • ejection fraction
  • clinical trial
  • open label
  • randomized controlled trial